Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.6350
+0.0350 (5.83%)
Aug 13, 2025, 5:23 PM GMT+1
Paramount Global Market Cap
Aptamer Group has a market cap or net worth of 15.97 million as of August 13, 2025. Its market cap has increased by 1,323.46% in one year.
Market Cap
15.97M
Enterprise Value
14.64M
Revenue
1.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.64
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 15.97M, a decrease of -83.63%. That is a compound annual growth rate of -39.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 15.97M | 124.70% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.37B |
| GSK plc | 55.99B |
| Haleon | 31.89B |
| Smith & Nephew | 11.72B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.85B |
| Oxford Nanopore Technologies | 2.07B |
| HUTCHMED (China) | 1.93B |